A detailed history of Wd Rutherford LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Wd Rutherford LLC holds 234 shares of LLY stock, worth $212,783. This represents 0.11% of its overall portfolio holdings.

Number of Shares
234
Previous 240 2.5%
Holding current value
$212,783
Previous $186,000 13.44%
% of portfolio
0.11%
Previous 0.1%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$724.87 - $909.04 $4,349 - $5,454
-6 Reduced 2.5%
234 $211,000
Q1 2024

Apr 16, 2024

BUY
$592.2 - $792.28 $142,128 - $190,147
240 New
240 $186,000
Q2 2023

Jul 18, 2023

BUY
$350.74 - $468.98 $182,384 - $243,869
520 New
520 $243,000
Q4 2022

Jan 30, 2023

SELL
$321.55 - $374.67 $20,900 - $24,353
-65 Reduced 11.11%
520 $190,000
Q3 2022

Nov 03, 2022

BUY
$296.48 - $337.87 $4,447 - $5,068
15 Added 2.63%
585 $189,000
Q4 2020

Feb 08, 2021

BUY
$130.46 - $172.63 $74,362 - $98,399
570 New
570 $96,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $864B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Wd Rutherford LLC Portfolio

Follow Wd Rutherford LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wd Rutherford LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wd Rutherford LLC with notifications on news.